[Cognitive impairments in alcohol dependence: From screening to treatment improvements]
- PMID: 26774623
- DOI: 10.1016/j.encep.2015.12.012
[Cognitive impairments in alcohol dependence: From screening to treatment improvements]
Abstract
Alcohol-related cognitive impairments are largely underestimated in clinical practice, even though they could limit the benefit of alcohol treatment and hamper the patient's ability to remain abstinent or to respect his/her therapeutic contract. These neuropsychological deficits can impact the management of patients well before the development of the well-known Korsakoff's syndrome. Indeed, even in the absence of ostensible neurological complications, excessive and chronic alcohol consumption results in damage of brain structure and function. The frontocerebellar circuit and the circuit of Papez, respectively involved in motor and executive abilities and episodic memory, are mainly affected. Those brain dysfunctions are associated with neuropsychological deficits, including deficits of executive functions, episodic memory, social cognition, as well as visuospatial and motor abilities. Such cognitive disorders can interfere with the motivation process to abandon maladjusted drinking behavior in favor of a healthier lifestyle (such as abstinence or controlled alcohol consumption). They can also limit the patient's capacity to fully benefit from treatment (notably psychoeducation and cognitive-behavioural treatments) currently widely proposed in French Addiction departments. In addition, they may contribute to relapse which is multi-determinated. A neuropsychological assessment appears therefore crucial to take relevant clinical decisions. However, very few addiction departments have the human and financial resources to conduct an extensive neuropsychological examination of all patients with alcohol dependence. Some brief screening tools can be used, notably the MOntreal Cognitive Assessment and the Brief Evaluation of Alcohol-Related Neuropsychological Impairments, which has been especially designed to assess cognitive and motor deficits in alcoholism. These tools can be used by non-psychologist clinicians to detect alcohol-related cognitive deficits, which require an extensive cognitive examination conducted by a neuropsychologist. The presence of cognitive dysfunctions in patients early in abstinence should encourage clinicians to adjust the modalities of the treatment. The fact to favor recovery of cognitive functions and brain volumes with abstinence or drastic reduction of alcohol consumption could be a first way to make it possible for patients to be cognitively able to benefit from treatment. Further studies are required to determine whether specifically designed cognitive remediation could boost (accelerate or increase) the recovery of brain functioning. Additionally, a potential effect of thiamine to limit alcohol-related cognitive deficits before the development of neurological complications remains to be determined. In this review, we presented the pattern of structural brain damage and the associated cognitive and motor impairments in alcohol-dependent patients. We then emphasized the harmful effects of neuropsychological deficits in the management of these patients. We also pointed how relevant it is to screen patients with neuropsychological impairments and we focused on the presentation of two brief screening tools for cognitive impairments, especially designed for alcohol-related deficits or not. Finally, we reported how these neuropsychological impairments could be taken into consideration the treatment of alcohol addiction by adjusting its timing and modalities.
Keywords: Alcohol dependence; Alcoolodépendance; Dépistage; Executive functions; Fonctions exécutives; Neuropsychological rehabilitation; Neuropsychologie; Neuropsychology; Réhabilitation cognitive; Screening; Traitement; Treatment.
Copyright © 2015 L’Encéphale, Paris. Published by Elsevier Masson SAS. All rights reserved.
Similar articles
-
Validation of a brief screening tool for alcohol-related neuropsychological impairments.Alcohol Clin Exp Res. 2015 Nov;39(11):2249-60. doi: 10.1111/acer.12888. Alcohol Clin Exp Res. 2015. PMID: 26503070
-
[Alcohol-related neuropsychological impairments: Nature, impact and detection].Presse Med. 2016 Dec;45(12 Pt 1):1124-1132. doi: 10.1016/j.lpm.2016.01.030. Epub 2016 Mar 30. Presse Med. 2016. PMID: 27039333 French.
-
[Secondary benefits of cognitive rehabilitation for a chronic ethylic patient: effects on disorder consciousness, motivation, and global therapeutic cooperation].Encephale. 2014 Jun;40(3):263-70. doi: 10.1016/j.encep.2013.03.007. Epub 2013 Aug 5. Encephale. 2014. PMID: 23928068 French.
-
Component processes of memory in alcoholism: pattern of compromise and neural substrates.Handb Clin Neurol. 2014;125:211-25. doi: 10.1016/B978-0-444-62619-6.00013-6. Handb Clin Neurol. 2014. PMID: 25307577 Review.
-
Executive Functions, Memory, and Social Cognitive Deficits and Recovery in Chronic Alcoholism: A Critical Review to Inform Future Research.Alcohol Clin Exp Res. 2017 Aug;41(8):1432-1443. doi: 10.1111/acer.13431. Epub 2017 Jul 4. Alcohol Clin Exp Res. 2017. PMID: 28618018 Free PMC article. Review.
Cited by
-
Neuropsychological Impairment in Detoxified Alcohol-Dependent Subjects with Preserved Psychosocial Functioning.Front Psychiatry. 2017 Sep 29;8:193. doi: 10.3389/fpsyt.2017.00193. eCollection 2017. Front Psychiatry. 2017. PMID: 29033861 Free PMC article.
-
Towards a Dynamic Exploration of Vision, Cognition and Emotion in Alcohol-Use Disorders.Curr Neuropharmacol. 2019;17(6):492-506. doi: 10.2174/1570159X16666180828100441. Curr Neuropharmacol. 2019. PMID: 30152285 Free PMC article. Review.
-
Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients.Sci Rep. 2020 Oct 13;10(1):17163. doi: 10.1038/s41598-020-74155-0. Sci Rep. 2020. PMID: 33051508 Free PMC article.
-
Mefenamic Acid Attenuates Chronic Alcohol Induced Cognitive Impairment in Zebrafish: Possible Role of Cholinergic Pathway.Neurochem Res. 2018 Jul;43(7):1392-1404. doi: 10.1007/s11064-018-2554-3. Epub 2018 May 23. Neurochem Res. 2018. PMID: 29796737
-
Clinical, Genomic, and Neurophysiological Correlates of Lifetime Suicide Attempts among Individuals with an Alcohol Use Disorder.Complex Psychiatry. 2025 Feb 13;11(1):1-11. doi: 10.1159/000543222. eCollection 2025 Jan-Dec. Complex Psychiatry. 2025. PMID: 40061584 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical